The Latest: WHO endorses antibody treatment for some people
ABC News
The World Health Organization is recommending a pricey antibody treatment for certain coronavirus patients in the latest update to its guidelines for treating people with COVID-19
LONDON — The World Health Organization is recommending a pricey antibody treatment for certain coronavirus patients in the latest update to its guidelines for treating people with COVID-19.
The new guidelines, published Friday in the journal BMJ, say the two antibodies - casirivimab and imdevimab = made by Regeneron should be given to people infected with COVID-19 who are at highest risk of hospitalization and to people whose own immune systems have not mounted a response.
The U.N. health agency said the new advice was based on evidence from experimental trials, including a British-run study that is the world’s largest for testing potential COVID-19 treatments.
In the U.S., the Regeneron treatment is mostly recommended for people with mild to moderate COVID-19, to prevent them from needing hospitalization.
